These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15967786)

  • 41. Antigen presentation by B lymphocytes: mechanisms and functional significance.
    Abbas AK
    Semin Immunol; 1989 Sep; 1(1):5-12. PubMed ID: 15630954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract.
    Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD
    Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
    Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
    Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
    Fearon DT; Carter RH
    Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells.
    Andrade MC; Albernaz MJ; Araújo MS; Santos BP; Teixeira-Carvalho A; Faria AM; Martins-Filho OA
    Scand J Immunol; 2009 Sep; 70(3):226-37. PubMed ID: 19703012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Killing of non-Hodgkin lymphoma cells by autologous CD19 engineered T cells.
    Cheadle EJ; Gilham DE; Thistlethwaite FC; Radford JA; Hawkins RE
    Br J Haematol; 2005 May; 129(3):322-32. PubMed ID: 15842655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.
    Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F
    Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microsignalosomes: spatially resolved receptor signalling.
    Treanor B; Harwood NE; Batista FD
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1014-8. PubMed ID: 19754442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N; King CA; Vitetta ES; Stevenson FK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyreactive antigen-binding B cells in the peripheral circulation are IgD+ and B7-.
    Chen ZJ; Shimizu F; Wheeler J; Notkins AL
    Eur J Immunol; 1996 Dec; 26(12):2916-23. PubMed ID: 8977286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity.
    El Shikh ME; El Sayed RM; Szakal AK; Tew JG
    J Immunol; 2009 Mar; 182(6):3482-91. PubMed ID: 19265126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
    Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B cells as antigen presenting cells.
    Rodríguez-Pinto D
    Cell Immunol; 2005 Dec; 238(2):67-75. PubMed ID: 16574086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B cells acquire antigen from target cells after synapse formation.
    Batista FD; Iber D; Neuberger MS
    Nature; 2001 May; 411(6836):489-94. PubMed ID: 11373683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4.
    Mongini PK; Tolani S; Fattah RJ; Inman JK
    Cell Immunol; 2002; 216(1-2):50-64. PubMed ID: 12381350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
    Mongini PK; Inman JK
    Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole-body autoradiography reveals that the Peptostreptococcus magnus immunoglobulin-binding domains of protein L preferentially target B lymphocytes in the spleen and lymph nodes in vivo.
    Smith D; D'Argy R; Nilsson M; Yrlid U; de Jersey J; Björck L; Wick MJ
    Cell Microbiol; 2004 Jul; 6(7):609-23. PubMed ID: 15186398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis.
    Khine AA; Firtel M; Lingwood CA
    J Cell Physiol; 1998 Aug; 176(2):281-92. PubMed ID: 9648915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.